Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer.
Saved in:
| Title: | Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer. |
|---|---|
| Authors: | Spring LM; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Han H; Moffitt Cancer Center-McKinley Outpatient Clinic, Tampa, FL, USA., Liu MC; Mayo Clinic, Rochester, MN, USA., Hamilton E; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA., Irie H; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Santa-Maria CA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Reeves J; Florida Cancer Specialists-South/Sarah Cannon Research Institute, Fort Myers, FL, USA., Pan P; GSK, Waltham, MA, USA.; EQRx, Cambridge, MA, USA., Shan M; GSK, Waltham, MA, USA.; Translational Discovery & Development, Boston Pharmaceuticals, Boston, MA, USA., Tang Y; GSK, Waltham, MA, USA., Graham JR; GSK, Waltham, MA, USA.; Alkermes Incorporated, Waltham, MA, USA., Hazard S; GSK, Waltham, MA, USA.; Bicycle Therapeutics, Boston, MA, USA., Ellisen LW; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., Isakoff SJ; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. SISAKOFF@mgh.harvard.edu. |
| Source: | Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1138. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35931884 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Spring+LM%22">Spring LM</searchLink>; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Han+H%22">Han H</searchLink>; Moffitt Cancer Center-McKinley Outpatient Clinic, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Liu+MC%22">Liu MC</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+E%22">Hamilton E</searchLink>; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Irie+H%22">Irie H</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Santa-Maria+CA%22">Santa-Maria CA</searchLink>; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Reeves+J%22">Reeves J</searchLink>; Florida Cancer Specialists-South/Sarah Cannon Research Institute, Fort Myers, FL, USA.<br /><searchLink fieldCode="AU" term="%22Pan+P%22">Pan P</searchLink>; GSK, Waltham, MA, USA.; EQRx, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shan+M%22">Shan M</searchLink>; GSK, Waltham, MA, USA.; Translational Discovery & Development, Boston Pharmaceuticals, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tang+Y%22">Tang Y</searchLink>; GSK, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Graham+JR%22">Graham JR</searchLink>; GSK, Waltham, MA, USA.; Alkermes Incorporated, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hazard+S%22">Hazard S</searchLink>; GSK, Waltham, MA, USA.; Bicycle Therapeutics, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ellisen+LW%22">Ellisen LW</searchLink>; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Isakoff+SJ%22">Isakoff SJ</searchLink>; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. SISAKOFF@mgh.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1138. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35931884 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s43018-022-00430-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1138 Titles: – TitleFull: Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Spring LM – PersonEntity: Name: NameFull: Han H – PersonEntity: Name: NameFull: Liu MC – PersonEntity: Name: NameFull: Hamilton E – PersonEntity: Name: NameFull: Irie H – PersonEntity: Name: NameFull: Santa-Maria CA – PersonEntity: Name: NameFull: Reeves J – PersonEntity: Name: NameFull: Pan P – PersonEntity: Name: NameFull: Shan M – PersonEntity: Name: NameFull: Tang Y – PersonEntity: Name: NameFull: Graham JR – PersonEntity: Name: NameFull: Hazard S – PersonEntity: Name: NameFull: Ellisen LW – PersonEntity: Name: NameFull: Isakoff SJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2022 Sep Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2662-1347 Numbering: – Type: volume Value: 3 – Type: issue Value: 9 Titles: – TitleFull: Nature cancer Type: main |
| ResultId | 1 |